PDCD1 and cancer: Currently, the majority of companion diagnostics for PD-1/PD-L1 inhibitors measure PD-L1 expression level on either cancer cells alone, or on both cancer cells and infiltrating immune cells, but seldomly on immune cells only (18, 84).